The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSSA.L Regulatory News (SSA)

  • There is currently no data for SSA

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Sistema PJSFC: Sistema announces financial results for the third quarter 2022

15 Dec 2022 07:00

Sistema PJSFC (SSA) Sistema PJSFC: Sistema announces financial results for the third quarter 2022 15-Dec-2022 / 10:00 MSK Dissemination of a Regulatory Announcement, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement.


Sistema announces financial results for the third quarter 2022

 

Moscow, Russia – 15 December 2022 – Sistema PJSFC (“Sistema”, the “Corporation”, or together with its subsidiaries and affiliates the “Group”) (LSE: SSA, MOEX: AFKS), a Russian publicly traded investment company, announces its unaudited consolidated financial results in accordance with International Financial Reporting Standards (IFRS) for the third quarter of 2022 (3Q 2022), ending 30 September 2022.

Sistema results review[1]

 

(RUB mln)

3Q 2022

3Q 2021

Change

9M 2022

9M 2021

Change

Consolidated revenue

239,733

219,552

9.2%

658,630

559,882

17.6%

Adj. OIBDA

70,137

77,206

(9.2%)

228,021

196,404

16.1%

Operating income

 33,872

41,533

(18.4%)

116,116

97,059

19.6%

Net profit/(loss) attributable to Sistema

 28,354

888

3,091.7%

4,490

(5,395)

n/a

Adj. net profit/(loss) attributable to Sistema

 28,100  

2,292

1,125.9%

3,514

(3,494)

n/a

In 3Q 2022, Sistema's consolidated revenue increased by 9.2% year-on- year to RUB 239.7 billion due to the consolidation of Etalon Group's results since May 2022 as well as higher revenue at a number of key assets: at Medsi, thanks to the acquisition and opening of new clinics as well as increased patient flows; at MTS, due to continued growth in the telecom, fintech and media business verticals; and at Binnopharm Group, as a result of a significant increase in sales in the retail segment.

The Group's adjusted OIBDA decreased by 9.2% year-on-year to RUB 70.1 billion in 3Q 2022 due to a decline in Segezha Group’s financial results amid the considerable appreciation of the ruble year-on-year and the ongoing transformation of the company's sales geography, and also as a result of the postponement of crop sales at Steppe to future periods.

Group capex decreased by 39.8% to RUB 28.6 billion in 3Q 2022 due to forward investments on the part of key portfolio companies in prior periods.

The Corporate Centre's net financial liabilities increased by 10.0% year-on- year and decreased by 2.0% quarter-on-quarter to RUB 229.5 billion. The Corporate Centre's cash balance was RUB 16.4 billion. A portion of free cash flow, in the amount of RUB 15.3 billion, was invested in highly liquid securities. The Group's net financial liabilities amounted to RUB 935.4 billion.

Tagir Sitdekov, Sistema President: “Sistema has demonstrated sustainable business growth, reflecting the diversification of our investment portfolio and strong management at our Group companies. Our assets have been adapting to the new business environment, reshaping supply and logistical chains, creating new opportunities for growth and maintaining a high level of financial discipline. We will continue to implement our strategy, which is aimed at the development of leading companies in the Russian market in the interests of all stakeholders”.For further information, please visit www.sistema.ru or contact:

Investor Relations

Sergei Levitskiy

Tel: +7 (495) 730 66 00

s.levitskiy@sistema.ru

 

Public Relations

Sergei Kopytov

Tel.: +7 (495) 730 17 05

kopytov@sistema.ru

Sistema PJSFC is a publicly traded diversified Russian holding company in the sectors of telecommunications, high technology, financial services, retail, e commerce, paper and packaging, agriculture, real estate, tourism and medical services. The company was founded in 1993. Revenue in 2021 was RUB 802.4 billion; total assets equalled RUB ⁠1.8 trillion as of 31 December 2021. Sistema’s global depositary receipts are listed under the “SSA” ticker on the London Stock Exchange. Sistema’s ordinary shares are listed under the “AFKS” ticker on the Moscow Exchange. Website: www.sistema.ru.

 

The Company is not an investment company, and is not and will not be registered as such, under the U.S. Investment Company Act of 1940.

 

Some of the information in this press release may contain projections or other forward-looking statements regarding future events or the future financial performance of Sistema. You can identify forward looking statements by terms such as "expect,” "believe,” "anticipate,” "estimate,” "intend,” "will,” “could,” "may" or "might" the negative of such terms or other similar expressions. We wish to caution you that these statements are only predictions and that actual events or results may differ materially. We do not intend to update these statements to reflect events and circumstances occurring after the date hereof or to reflect the occurrence of unanticipated events. Many factors could cause the actual results to differ materially from those contained in our projections or forward-looking statements, including, among others, general economic conditions, our competitive environment, risks associated with the deterioration of the geopolitical situation, as well as many other risks specifically related to Sistema and its operations.

 

 


The Group’s financial performance adjusted for accruals related to the LTI programme at portfolio companies and the impairment of MTS assets, as well as for Segezha Group’s financial expenses associated with the revaluation of interest rate swaps. The Corporate Centre’s financial liabilities net of cash and cash equivalents are presented based on management accounts. The Group’s financial liabilities include finance leases and are net of cash and cash equivalents and deposits in banks.

AttachmentFile: Sistema 3Q 2022 Financial Results
ISIN:US48122U2042
Category Code:QRT
TIDM:SSA
LEI Code:213800JSZ2UUK4QQK694
Sequence No.:208596
EQS News ID:1512839
 
End of AnnouncementEQS News Service

UK Regulatory announcement transmitted by EQS Group AG. The issuer is solely responsible for the content of this announcement.

Date   Source Headline
30th Sep 201912:40 pmEQSSistema PJSFC: Sistema reports acquisition of shares under buyback programme
25th Sep 201911:00 amEQSSistema PJSFC: Sistema rating raised to ruA by Expert RA
23rd Sep 20195:30 pmEQSSistema PJSFC: Sistema reports acquisition of shares under buyback programme
17th Sep 20197:45 amEQSSistema PJSFC: Sistema launches RUB 3.0 billion share repurchase programme
30th Aug 201911:11 amEQSSistema PJSFC: Sistema credit rating raised to BB- by S&P
29th Aug 20198:11 amEQSSistema PJSFC: Sistema announces financial results for the second quarter 2019
12th Aug 20197:45 amEQSSistema PJSFC: Sistema to sell 49% of Leader Invest to Etalon Group
8th Aug 20197:50 amEQSSistema PJSFC: Sistema completes transaction to become shareholder of pharmaceutical businesses Sintez and Biocom
19th Jul 20193:15 pmEQSSistema PJSFC: Sistema closes order book on RUB 10 bn series 001Р-11 exchange-traded bonds
2nd Jul 20195:45 pmEQSSistema PJSFC: Changes in the shareholdings of members of the Board of Directors in Sistema PJSFC
1st Jul 20197:55 amEQSSistema PJSFC: Sistema announces results of AGM and Board of Directors meeting
25th Jun 20192:58 pmEQSSistema PJSFC: Report on Payments to Governments for 2018
17th Jun 20198:45 amEQSSistema PJSFC: Sistema attracts unsecured loan from VTB Bank (PJSC)
7th Jun 201910:38 amEQSSistema PJSFC: Sistema to acquire pharmaceutical companies Sintez and Biocom from Marathon Group
4th Jun 20198:01 amEQSSISTEMA ANNOUNCES FINANCIAL RESULTS FOR THE FIRST QUARTER 2019
20th May 20198:00 amEQSSistema announces decisions of the Board of Directors
17th May 20193:00 pmEQSSistema PJSFC: Sistema redeems USD500 million Eurobond
6th May 20195:00 pmEQSSistema PJSFC: Information on a transaction under the MTS share buyback programme
29th Apr 20194:00 pmEQSSistema Annual Report 2018
29th Apr 20197:46 amEQSSistema PJSFC: Sistema increases its stake in Ozon
26th Apr 20198:05 amEQSSistema PJSFC: Correction: Sistema and VTB to create a major pharmaceuticals holding
26th Apr 20198:00 amEQSSistema PJSFC: RDIF, RCIF and Middle Eastern investors to acquire stake in OBL Pharm
3rd Apr 20195:00 pmEQSSistema PJSFC: Information on a transaction under the MTS share buyback programme
3rd Apr 20198:16 amEQSSISTEMA ANNOUNCES FINANCIAL RESULTS FOR THE FOURTH QUARTER AND FULL YEAR 2018
1st Apr 20197:48 amEQSSistema announces decisions of the Board of Directors
28th Mar 20193:00 pmEQSSistema closes order book on RUB 10 bn series 001P-10 exchange-traded bonds
5th Mar 20194:00 pmEQSSistema PJSFC: Information on a transaction under the MTS share buyback programme
28th Feb 201912:03 pmEQSSistema PJSFC: Sistema closes order book on RUB 10 bn series 001P-09 exchange-traded bonds
21st Feb 20194:47 pmEQSSistema PJSFC: Acquisition of Sistema shares by Corporation employees
19th Feb 20194:45 pmEQSSistema acquires stake in Ozon from MTS
19th Feb 20194:00 pmEQSSistema becomes largest shareholder of Etalon Group
19th Feb 20194:00 pmRNSSistema Becomes Shareholder of Etalon Group
19th Feb 20197:00 amEQSSistema divests 51% stake in Leader Invest
12th Feb 20194:00 pmEQSSistema divests a stake in MTS Bank
6th Feb 20194:30 pmEQSSistema PJSFC: Sistema successfully completes secondary placement of series 001P-07 bonds
4th Feb 20194:00 pmEQSSistema PJSFC: Information on a transaction under the MTS share buyback programme
28th Dec 20186:55 amEQSSistema and VTB to create a major pharmaceuticals holding
14th Dec 20185:29 pmEQSChanges in the shareholdings of members of the Board of Directors in Sistema PJSFC
29th Nov 20185:20 pmRNSChanges in the shareholdings of members of the BoD
27th Nov 20187:06 amRNSSISTEMA ANNOUNCES FINANCIAL RESULTS FOR 3Q 2018
12th Nov 20184:00 pmEQSSistema PJSFC: Information on a transaction under the MTS share buyback programme
8th Oct 20183:10 pmRNSSistema rating raised to ruA- by Expert RA
3rd Oct 20185:00 pmRNSTransaction under the MTS share buyback programme
11th Sep 201811:30 amRNSAgreement with CapitalBio Technology and RCIF
10th Sep 20187:50 amRNSSistema announces decisions of Board of Directors
4th Sep 20185:00 pmRNSTransaction under the MTS share buyback programme
30th Aug 20188:00 amRNSFINANCIAL RESULTS FOR THE SECOND QUARTER 2018
23rd Aug 201810:40 amRNSSistema improves position in FTSE4Good index
7th Aug 20185:45 pmRNSTransaction under the MTS share buyback programme
30th Jul 201810:30 amRNSSistema secures credit facility from Otkritie Bank

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.